- 908 Devices ( NASDAQ: MASS ) completed the acquisition of privately-held Braunschweig, Germany-based TRACE Analytics, provider of on-line analysis and sampling systems for biotech applications.
- The purchase consideration includes an initial cash payment of $15.3M and up to an additional $2M of contingent cash consideration on the achievement of certain milestones over the next two years.
- The company expects the acquired technology to enable its mass spec devices as on-line bioprocess monitors.
For further details see:
908 Devices acquires TRACE Analytics for $15M